Is it safe for a pregnant woman to use Orajel (benzocaine oral gel)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Safety of Orajel (Benzocaine) During Pregnancy

Orajel and other benzocaine-containing products should be avoided during pregnancy due to the lack of safety data in pregnant women and the risk of methemoglobinemia, a potentially life-threatening complication.

Key Considerations

The FDA drug label for Orajel does not provide specific guidance regarding use during pregnancy 1. This absence of pregnancy-specific warnings or safety data is itself a red flag when considering use in pregnant women, as medications safe for pregnancy typically include this information prominently.

Primary Safety Concern: Methemoglobinemia

Benzocaine carries a well-documented risk of methemoglobinemia, a serious condition where hemoglobin cannot effectively carry oxygen:

  • Severe cases have been reported even with standard over-the-counter use, including a case with a lethal methemoglobin level of 69.9% in a child using 7.5% benzocaine gel 2
  • This complication can occur with topical application and does not require ingestion 2, 3, 4
  • Methemoglobinemia presents with cyanosis, hypoxia unresponsive to oxygen, and can be life-threatening to both mother and fetus
  • The condition requires prompt treatment with methylene blue 2, 4

Pregnancy-Specific Risks

While the provided guideline addresses medication safety in pregnancy, it does not specifically mention benzocaine 5. However, applying the general principle from this guideline: medications without established safety profiles should be avoided during pregnancy unless benefits clearly outweigh risks.

For oral pain relief during pregnancy:

  • The risk of fetal hypoxia from maternal methemoglobinemia could be catastrophic
  • Pregnant women have altered drug metabolism that may increase susceptibility to adverse effects
  • Alternative pain management strategies exist (acetaminophen for systemic pain, dental evaluation for definitive treatment)

Clinical Algorithm

When a pregnant patient requests Orajel:

  1. Do not recommend benzocaine products during pregnancy
  2. Refer for dental evaluation if toothache is present - the underlying problem needs definitive treatment
  3. Suggest safer alternatives:
    • Acetaminophen (Tylenol) for pain relief - well-established safety profile in pregnancy
    • Salt water rinses for minor oral irritation
    • Ice packs applied externally for localized pain
  4. Urgent dental care is preferable to topical anesthetics, as untreated dental infections pose their own risks to pregnancy

Important Caveats

  • Even in non-pregnant populations, benzocaine should not be used longer than 4 weeks 1
  • The efficacy of benzocaine for toothache is temporary at best 6, 7 - it does not address the underlying problem
  • Persistent tooth pain requires professional dental evaluation, not continued self-treatment with topical agents

The risk-benefit analysis clearly favors avoiding benzocaine during pregnancy given the potential for life-threatening methemoglobinemia, lack of pregnancy safety data, and availability of safer alternatives.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.